Glatt Pharmaceutical Services
Glatt Pharmaceutical Services is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
Multi-centre, double-blind, placebo-controlled, randomised trial to prove the efficacy and safety of Silexan® (WS®1265) in patients with a major depressive episode of mild to moderate severity
Sponsor Dr. Willmar Schwabe GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase III randomised, double-blind, placebo-controlled, multicentre efficacy and safety clinical trial of angiotensin II in paediatric patients of 0 to 17 years of age with refractory hypotension in distributive shock receiving fluid resuscitation and standard-of-care vasopressors
Sponsor Paion Pharma GmbH
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Glatt Pharmaceutical Services?
The 2026-10-09 snapshot links Glatt Pharmaceutical Services to 2 distinct CTIS trials. Recorded services include IMP Distribution to sites, Medicinal product management, pack the vials into secondary packaging, label the Giapreza vials and secondary packaging with a compliant label, provide QP certification of the IMP finished product. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Glatt Pharmaceutical Services?
The most frequently recorded therapeutic areas are Psychiatry. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Glatt Pharmaceutical Services conducted?
The linked trials record locations in 5 countries, including Germany, Austria, Spain, France, Italy. These are trial locations, not confirmed office locations or countries where Glatt Pharmaceutical Services delivered services.
What can this page tell me about Glatt Pharmaceutical Services's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Glatt Pharmaceutical Services. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Glatt Pharmaceutical Services GmbH & Co. KG